As many of our customers are aware, in 2009 the United States Congress granted the Food and Drug Administration authority to regulate all tobacco products, including electronic cigarettes. As part of the process of enacting regulations for these products, the FDA is currently considering whether to classify electronic cigarettes as "modified risk tobacco products." The modified risk tobacco product designation was intended by Congress to address traditional combustible tobacco products such as cigarettes and non-combustible products containing tobacco leaf such as spitting tobacco. In response to a request for comments from the FDA, we have made clear that it is our position that the FDA should not lump electronic cigarettes in with these traditional, harmful tobacco products and treat us as modified risk tobacco products, but should treat our products separately as the new and innovative products that they are.
Please, make your voice heard in this debate. FDA has an obligation to listen to all interested parties, including consumers. Please write to the FDA's Center for Tobacco Products and encourage it to treat electronic cigarettes differently than traditional cigarettes. Write to the Center for Tobacco Products at the following address and encourage it to establish regulations that do not treat electronic cigarettes like traditional combustible and tobacco leaf-containing products at the following address:
Center for Tobacco Products (CTP)
U.S. Food and Drug Administration
9200 Corporate Boulevard
Room 130T
Rockville, Maryland 20850
We will have further updates once the FDA issues its proposed rulemaking for modified risk tobacco products.
Please, make your voice heard in this debate. FDA has an obligation to listen to all interested parties, including consumers. Please write to the FDA's Center for Tobacco Products and encourage it to treat electronic cigarettes differently than traditional cigarettes. Write to the Center for Tobacco Products at the following address and encourage it to establish regulations that do not treat electronic cigarettes like traditional combustible and tobacco leaf-containing products at the following address:
Center for Tobacco Products (CTP)
U.S. Food and Drug Administration
9200 Corporate Boulevard
Room 130T
Rockville, Maryland 20850
We will have further updates once the FDA issues its proposed rulemaking for modified risk tobacco products.
